BioLight Life Sciences Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Stock Symbol
  • BOLT
Stock Symbol
  • Investments
  • 8
  • Share Price
  • $3.49
  • (As of Thursday Closing)

BioLight Life Sciences General Information

Description

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Stock Exchange
TAE
Primary Office
  • Kiryat Atidim
  • Building 3, 5th Floor
  • Tel Aviv 6158101
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioLight Life Sciences Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.49 $3.49 $1.69 - $4.18 $15.8M 4.54M 5.19K -$0.87

BioLight Life Sciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV (3,023) (3,899) (4,230) (1,309)
Revenue 58 9 0 919
EBITDA (4,147) (3,999) (4,059) 16,530
Net Income (3,936) (3,888) (3,530) 18,183
Total Assets 19,187 20,161 21,645 23,972
Total Debt 246 289 130 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioLight Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioLight Life Sciences‘s full profile, request access.

Request a free trial

BioLight Life Sciences Executive Team (3)

Name Title Board Seat Contact Info
Suzana Nahum-Zilberberg Chief Executive Officer
Yaacov Michlin Chief Executive Officer
Itai Bar-Natan Chief Financial Officer
To view BioLight Life Sciences’s complete executive team members history, request access »

BioLight Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioLight Life Sciences‘s full profile, request access.

Request a free trial

BioLight Life Sciences Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 21-Mar-2021 0000 00000 000 Decision/Risk Analysis 000000 0000000
000000 00000 20-Jul-2020 00000 00000 00 000.00 Other Devices and Supplies
000000000 11-Sep-2019 00000 00000 00 00.00 Surgical Devices
0000000 25-Nov-2015 00000 00000 00 00.00 Surgical Devices 000000 00000-0000000000
BioLight & Rock-One (Joint Venture) 02-Apr-2015 Joint Venture Medical Supplies 000000 00000-0000000000
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

BioLight Life Sciences Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 25-Nov-2015 00000 00000 00 00.00 Completed
  • 2 buyers
Ioptima Merger/Acquisition Completed
  • 2 buyers
To view BioLight Life Sciences’s complete exits history, request access »